Calendario›SNY›Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

Ensayo de Sanofi en Chronic Immune Thrombocytopenia · Primary Immune Thrombocytopenia · Adult Immune Thrombocytopenia (del registro, en inglés).

Fase

no aplica

Estado

Completado

Participantes

97

previstos

Centros

4

Fin del objetivo primario

nov 2025

fecha real

Qué significa cada fase y cada estado.

Estudio observacional. Comenzó en ene 2025.

Qué mide

Prevalence of impaired cognitive status among adult Immune Thrombocytopenia patients (Day 1 (Index date)) (del registro, en inglés)

Cómo lo describe el promotor

En el documentoEn inglés, del registroThis is a multi-center, hospital based, cross-sectional study based on data from patient medical records, including laboratory results. The study will include adult patients with chronic (\> 1 year duration) primary Immune Thrombocytopenia (ITP) only. Patients will be identified based on a laboratory confirmed diagnosis of ITP in the medical records, where there is also a physician-confirmed diagnosis of primary ITP. If patients consent to take part in the study, a routine clinical visit will also serve as the study visit. Patients who do not have a routine visit scheduled during the study period but who would otherwise be eligible may be contacted by the site. In such cases, clinicians may use their discretion to schedule a visit specifically for study purposes. All study participants will have a routine blood test as part of their standard clinical care at the study visit, and this same procedure will be used to collect supplementary blood samples to assess a variety of biomarkers. Data will be collected using a combination of chart review, clinical outcome assessment administration, and laboratory results through blood tests.

Más ensayos de SNY

Todos los de SNY, en su ficha.

Ficha completa en ClinicalTrials.gov (NCT06665308), actualizada en ene 2026.